B CELL ACTIVATION IN VIVO BY NONANTIGEN-SPECIFIC INTERACTION WITH T CELLS : FREQUENCY OF IMMUNE RESPONSES INCREASED BY IMMUNIZATION WITH TWO ANTIGENS by Tito, T. et al.
B  CELL ACTIVATION  IN  VIVO  BY  NONANTIGEN-SPECIFIC 
INTERACTION  WITH  T  CELLS 
FREQUENCY  OF  IMMUNE  RESPONSES  INCREASED  BY  IMMUNIZATION  WITH  TWO 
ANTIGENS* 
BY  T.  ITO,{  G.  M.  SHEARER,§  D.  TRIZIO,{  AX,  D  G.  CUDKOWICZ 
(From the Department of Pathology, School of Medicine, State University of New York 
at Buffalo, Buffalo, New York 14214) 
(Received for publication 8 May  1972) 
There is substantial evidence for a  nonspecific mechanism of activation of thymus-inde- 
pendent bone marrow-derived precursors of immunocytes (B cells) in primary and secondary 
immune responses elicited in vitro (1-5) and in animals undergoing graft-versus-host reactions 
(6).  Thymus-derived cells primed  by immunogens other than the test  antigens  (not cross- 
reacting at the level of antibody-forming cells) may be utilized in such a mechanism (7). The 
common feature  of  most  reported  experiments is that preexposure  of  lymphoid  ceils  to  a 
priming antigen enhances the responsiveness of spleen cells to a second test antigen, provided 
that both immunogens are present at  the time of the second immunization. It is generally 
presumed that the enhancing effect is due to proliferation of thymus-derived cells with helper 
function for antibody formation by B cells (including antigen-reactive cells and their activated 
progeny, i.e.  inducer cells)  (T cells)  in response to the antigen administered first and to sub- 
sequent interaction of the activated thymic inducers with the subpopulations of B cells specific 
for the test antigens. It is plausible to propose that this type of T-B cell interaction is mediated 
by a diffusible nonantigen-specific product of activated T  cells (1, 8). 
We now report in vivo experiments describing nonspecific augmentation of 
murine immune responses  using mixtures of two xenogeneic  erythrocytes  as 
antigens for limiting numbers of potentially competent cells. Our experiments 
were designed to determine whether the antigens could be administered simul- 
taneously, and whether activation of T  or B cells by the priming antigen was 
necessary for  augmentation.  For  this  purpose  we  determined  the  frequency 
and magnitude of anti-sheep erythrocyte responses by transferred bone mar- 
row-thymus cell  mixtures under conditions in which only one cell  type was 
limiting. This approach originates from previous work, according to which the 
number of T  or B  cells  activated during primary immune responses  can be 
assessed by limiting dilution assays (9, 10). 
The  studies were  carried  out  using  a  syngeneic  cell  transfer system  in  (C57BL/10)< 
C3H/He)F1 female mice. The thymus of 6--8-wk old animals was the source of antigen-reactive 
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helper cells (ARC), and the bone marrow of adult mice provided precursors of immunocytes. 
Details of the preparation of cell  suspensions, the total  body irradiation of  recipients, the 
transplantation of cell mixtures, and the statistical procedures have heen given elsewhere  (9, 
10). A total of 5 X  l0 s washed erythrocytes were used for immunization, regardless of whether 
the red blood cells were from one or two species. 
Groups  of  10-14-wk  old  mice  were  exposed  to  X-  or-r-irradiation and  injected intra- 
venously within a  few hours with one of  the following  cell  mixtures:  (a)  fixed  number of 
1-3  X  10 r bone marrow cells, providing an excess of immunocyte precursors, together with 
graded numbers of thymocytes providing limiting numbers of  ARC.  (b)  Fixed number of 
5  X  10 ~ thymocytes together with limiting numbers of bone marrow cells. All irradiated mice 
were immunized intravenously 1 day later. The response was assessed in terins of the number 
of antibody-forming cells secreting -yM hemolysins, i.e. direct plaque-forming cells  (PFC), in 
the spleens of recipients at the time of peak response. 
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FIG. 1.  Percentage of recipient mice with spleens positive for anti-sheep PFC 8 days after 
transplantation of  13  15  X  106  bone marrow  cells  and  limiting numbers of  thymocytes. 
Symbols indicate observed percentages after immunization against SRB C alone (O) or against 
SRBC  +  HRBC  (A), and the fitted curves expected percentages according to the Poisson 
model. The probabilities of positive spleens for 106 transplanted thymocytes (and 95% con- 
fidence intervals) were 0.12  (0.09-0.15)  and 0.80  (0.58-1.10),  respectively. Dashed straight 
lines indicate the  number  of  thymocytes containing an  average  of  one  detectable ARC: 
8.33  X  106 (6.25-10.42)  thymocytes for the SRBC immunization plot, and 1.25 X  106  (0.91- 
1.72) for the SRBC  +  HRBC immunization plot. 
The antigens were sheep, chicken, burro,  or horse erythrocytes (SRBC, CRBC,  BRBC, 
and  HRBC,  respectively) in  different combinations. These  antigens were chosen because 
previous experiments demonstrated that the direct PFC which arose in the spleens of irradi- 
ated recipients of nonlimiting numbers of marrow-thymus cells in response to horse, burro, 
and chicken erythrocytes had little, if any, cross-reactivity with SRBC. 
The frequencies of thymic ARC available for activation by SRBC alone or by a mixture 
of SRBC  and  HRBC  were determined by  a  limiting dilution experiment. The  mice were 
irradiated (925 R)  and injected with 1.3-1.5  X  107 marrow cells together with graded num- 
bers of thymocytes, in a range extending from 0.16 to 40  X  106 cells, as indicated in Fig. 1. 
One day after transplantation, each recipient was given either 5 X  l0 s SRBC or a mixture of 
2.5  X  i0 s SRBC with an equal number of HRBC. A total of 204 mice received SRBC, and 
97  mice SRBC  +  HRBC.  Each thymocyte inoculum was given to at least 10  mice.  Direct 
PFC  of  recipient spleens were enumerated 8  days after transplantation, and  spleens were 
regarded as positive if the number of PFC was larger than 150. 
The  proportion  of  mice  with  positive  spleens increased  as  the  number  of 
transplanted thymocytes was raised from 6.2  X  l0  s to 4  X  107  in  the SRBC ITO,  SI4EARER,  TRIZIO,  AND  CUDI<OWICZ  383 
immunization series. The relationship between the number of thymocytes and 
the  proportion  of  responding  animals  conformed  to  the  predictions  of  the 
Poisson model. The estimated concentration of activated ARC  (calculated by 
the method of maximum likelihood)  was 0.12  in  106  (see legend of Fig.  1 for 
confidence intervals),  or one ARC  in 8.3  X  106  thymocytes. The results ob- 
tained  in  the  SRBC  +  HRBC  immunization  series  also  conformed  to  the 
Poisson model. However, the dilution curve was shifted to the left as the fre- 
quency of anti-sheep responses increased over the range of 1.6  X  105-1  X  107 
transplanted thymocytes (Fig. 1). The concentration of ARC detectable in this 
TABLE  I 
Frequency cf Anti-Sheep and Anti-Burro PFC Responses in Spleens of Irradiated- 
Reconstituted Mice after Immunization with Two Anligen Complexes 
No. of cells  Positive spleens for  Positive spleens for 
transplanted*  anti-SRBC PFC:~  anti-BRBC PFC~ 
Bone  Thymo-  Immunization 
marrow  cytes  Fraction  Per cent  PFC/spleen§  Fraction  Per cent  PFC/ 
(X  10  6)  (X 10  6)  4- s~  4- sE  spleen§ 
13-15  --  SRBC -b HRBC  0/10 
13-15  --  SRBC -}- CRBC  O/20 
30  --  BRBC 
30  --  SRBC -}- BRBC  1/5 
13-15  0.62  SRBC  1/10 
30  O.62  BRBC 
13-15  0.62  SRBC -}- HRBC  10/21 
30  0.62  SRBC "+" BRBC  10/11 
13-15  0.62  SRBC -b  CRBC  8/25 
0.03  50  SRB C  13/26 
0.03  50  SRBC -}- HRBC  8/23 
0.03  50  SRBC -{- CRBC  9/22 
355 
10 4-  9  218 
48  4-  11 
914.8 
324-9 
50 4-  10 
35  4-  10 
41  4-  n 
337  4-  170 
487  4-  132 
223  4-  67 
282  4-  30 
337  4-  50 
333  4-  90 
0/5 
0/5 
4/10  40 ±  15  251  4-  39 
8/11  73  4.  13  309  4-  70 
* After 925 R  of X-rays or 950 rads of a~Cs "y rays. 
Spleens with more than 200 direct PFC. 
§ Geometric mean 4- standard error. 
second series was ~-~7 times higher than after immunization with SRBC alone, 
i.e.,  it was 0.8  in  106  or one ARC  in  1.2  X  l0  G thymocytes. Despite the in- 
creased frequency of responses, the mean number of PFC per positive spleen 
remained comparable in the two experimental series, ranging from 300 to 800. 
Thus,  the  immunization  with  HRBC  and  SRBC  increased  the  number  of 
activated ARC detected by interaction with SRBC-specific precursors and pro- 
duction of anti-sheep PFC. 
We determined the effect of other combinations of xenogeneic erythlocytes 
on the  frequency of anti-sheep  and  anti-burro  PFC  responses.  Three sets of 
data are presented in Table I. First, irradiated control mice reconstituted with 
bone marrow cells alone failed to form significant numbers of PFC even upon 
immunization with  erythrocyte mixtures  (upper section of Table I).  Second, 384  NONANTIGEN-SPECIFIC :B-T  CELL  INTERACTION 
the proportion of responding animals increased both for anti-sheep and  anti- 
burro  PFC  upon  immunization  of  irradiated  mice  with  the  combinations 
SRBC +  BRBC and SRBC +  CRBC, provided that the number of reconsti- 
tuting thymocytes, but  not of marrow  cells,  was  limiting  (middle section of 
Table  I).  Third,  the  proportion  of  responding  animals  did  not  increase  for 
anti-sheep PFC upon immunization of irradiated mice with erythrocyte mix- 
tures if only the number of reconstituting marrow cells was limiting (lower sec- 
tion of Table I). 
The data show that the simultaneous stimulation of relatively small lymphoid 
cell  populations  bv  two  weakly  or  noncross-reacting  antigens  resulted  in  a 
severalfold increase  of the  number  of functional  antigen-sensitive  units.  By 
limiting one of the cell  types constituting these units of immune response, it 
was established that the effect was elicited exclusively at the level of T  cells. 
Two explanations can be offered for the increased activation of thymic ARC 
by antigen mixtures under these experimental conditions. The antigens  may 
have synergized in the triggering of specific ARC by promoting some form of 
T-T cell interaction (11) or by removing repressive functions (12), thus lower- 
ing the threshold for activation. However, the number of specific ARC activated 
by some of the priming antigens may have been considerably larger than that 
of SRBC-specific ARC2 Should T-B cell interactions be mediated by nonanti- 
gen-specific T-cell products (1, 8), then our results could be explained by dif- 
ferential "strength" of the admixed antigens reflected in the number of ARC 
activated. The two proposed explanations are not mutually exclusive. We con- 
sider it unlikely that these data can be accounted for simply by cross-reactions 
at the T-cell level (7)  since cross-activation of SRBC-specific B  cells was not 
achieved  with  BRBC  or  HRBC-educated  T  cells  in  two-step  experiments 
(9,  13). 
An important aspect of our experiments is the apparently common occurrence 
in vivo, without the necessity of graft-versus-host  reactions, of a  kind  of T-B 
cell interaction (via nonspecific mediators) not requiring associated recognition 
of carrier and hapten determinants by T  and B or by macrophage and B cells 
(via membrane-bound receptors). Most likely, our findings are a simplified ex- 
ample  of adjuvant effects recently associated  with  T-cell functions  (14,  15). 
The emerging picture is one of the thymus assuming the major role of modu- 
lating the immune response by a variety of mechanisms. 
SUMMARY 
The number of direct (3,M) hemolytic plaque responses of irradiated mice, 
repopulated with  relatively small  and limiting numbers of bone marrow  and 
thymus cells, was increased by the simultaneous immunization with two antigen 
1  Trizio, D., and G. Cudkowicz. Unpublished data for burro-speclfic  ARC of (C57BL/10 X 
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complexes instead of one. Anti-sheep responses were augmented by the follow- 
ing antigen combinations: SRBC  +  HRBC,  SRBC  +  BRBC,  and SRBC  + 
CRBC.  Limiting either  thymocytes or bone marrow cells indicated  that  the 
antigen mixtures acted at the level of T  ceils increasing severalfold the number 
of triggered  antigen-reactive cells.  It was concluded  that one of the antigens 
could  have influenced  the  triggering of antigen-reactive cells  specific for the 
other by promoting synergistic or derepressive T-T cell interactions. Moreover, 
bone marrow precursor cells could have been activated by the thymic inducers 
specific for the test antigens as well as by those specific for the second of the 
priming antigens. 
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